Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Open-market buy Director bought 23,745 shares at an average $1.78 ($42,304)
  2. 4 Open-market buy Director bought 26,010 shares at an average $1.79 ($46,588)
  3. 4 Open-market buy Director bought 33,315 shares at an average $1.91 ($63,639)
  4. 4 Open-market buy Director bought 21,808 shares at an average $2.03 ($44,282)
  5. 4 Open-market buy Director bought 18,331 shares at an average $2.08 ($38,215)
  6. 4 Other acquisition 10% owner acquired 40,099 shares (other)
  7. 4 Other acquisition 10% owner acquired 182,262 shares (other)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Other disposition Director disposed of 1,278,471 shares (other)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Director bought 67,326 shares at an average $2.25 ($151,282)
  19. 4 Open-market buy Director bought 10,000 shares at an average $2.21 ($22,097)
  20. 4 Open-market buy Director bought 50,000 shares at an average $2.21 ($110,263)

Page 17 of 34 · 675 filings